Literature DB >> 3045478

Mediastinal fibrosis complicating histoplasmosis.

J E Loyd1, B F Tillman, J B Atkinson, R M Des Prez.   

Abstract

Mediastinal fibrosis, the most serious late complication of remote infection by Histoplasma capsulatum, is a thick, dense fibrotic capsule which surrounds a small mediastinal focus of old caseous adenitis. The fibrotic process may accrue over prolonged periods and extend within the lumina of critical mediastinal structures to produce complete occlusion. We summarized clinical and radiographic data for 71 patients with mediastinal fibrosis; the criteria for inclusion were the clinical demonstration of occlusion of major central airways (trachea or mainstem bronchus) or major vessels (pulmonary arteries or veins) and the absence of other disease processes which might cause such obstruction. We selected 65 patients who met these criteria from the medical literature of the last 40 years and report 6 new cases from our experience. The majority of patients were diagnosed between ages 20 and 40. The most common symptoms included hemoptysis, dyspnea, and cough. An accentuated pulmonic component of the second heart sound, wheezing, and localized murmur were among the physical findings reported. Radiographic abnormalities consisted of mass lesions and atelectasis or infiltrates, but were often nonspecific. Chest radiography was deceptively normal in some patients, even in the presence of major central airway or vascular occlusion, especially when the focus was subcarinal. Computed tomography has particular promise to depict the mediastinal abnormalities in this process. Surgery had minimal therapeutic benefit. Because of incomplete followup, the mortality of 30% in this series surely does not represent the true overall mortality of mediastinal fibrosis.

Entities:  

Mesh:

Year:  1988        PMID: 3045478     DOI: 10.1097/00005792-198809000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  43 in total

1.  A 36-year-old man with hemoptysis.

Authors:  Darrell Tan; Michael Hutcheon; Tae Bong Chung
Journal:  CMAJ       Date:  2004-09-14       Impact factor: 8.262

2.  Further Progress in Understanding Fibrosing Mediastinitis.

Authors:  Stephen B Strock; Wendi Mason; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

3.  Treatment of SVC syndrome and hemoptysis in a patient with mediastinal fibrosis.

Authors:  Bradley P Thomas; Peter R Bream; Aaron P Milstone; Steven G Meranze
Journal:  Emerg Radiol       Date:  2006-03-30

4.  Fibrosing mediastinitis mimicking malignancy at CT: negative FDG uptake in integrated FDG PET/CT imaging.

Authors:  Semin Chong; Tae Sung Kim; Byung-Tae Kim; Eun Yoon Cho
Journal:  Eur Radiol       Date:  2006-08-30       Impact factor: 5.315

Review 5.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

6.  Fibrosing mediastinitis: an unusual cause of pulmonary symptoms.

Authors:  Meredith A Schade; Neena M Mirani
Journal:  J Gen Intern Med       Date:  2013-06-27       Impact factor: 5.128

Review 7.  Respiratory diseases.

Authors:  D G James; O M Sharma
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

8.  Idiopathic mediastinal fibrosis: report of a case.

Authors:  S Kinugasa; S Tachibana; M Kawakami; T Orino; R Yamamoto; S Sasaki
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

9.  Targeting B lymphocytes in progressive fibrosing mediastinitis.

Authors:  Blair D Westerly; Geoffrey B Johnson; Fabien Maldonado; James P Utz; Ulrich Specks; Tobias Peikert
Journal:  Am J Respir Crit Care Med       Date:  2014-11-01       Impact factor: 21.405

Review 10.  [Treatment of chronic mediastinitis].

Authors:  R Scheubel
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.